PT-141

History

PT-141 was developed during research involving melanocortin receptor agonists derived from alpha-melanocyte-stimulating hormone (α-MSH). Scientists investigating melanocortin signaling observed that certain peptide analogs exhibited effects distinct from pigmentation-related pathways, prompting further exploration into central nervous system receptor activity. As research expanded, PT-141 became an important tool for studying melanocortin receptor function and neuroendocrine signaling mechanisms. Investigators focused on understanding how activation of specific melanocortin receptor subtypes influenced behavior, hormonal regulation, and central nervous system communication. Today, PT-141 remains one of the most extensively studied melanocortin receptor agonists in neuroendocrine and behavioral research.

Research Findings

PT-141 is a synthetic melanocortin receptor agonist derived from alpha-melanocyte-stimulating hormone (α-MSH). It functions primarily through activation of melanocortin receptor pathways located within the central nervous system and has become a widely studied compound within neuroendocrine research. Researchers have investigated PT-141 due to its unique ability to influence melanocortin signaling pathways independent of many pigmentation-related mechanisms traditionally associated with α-MSH analogs. Experimental studies have explored the peptide's effects on neuroendocrine communication, behavioral signaling, and receptor-mediated physiological responses. One of the primary areas of scientific interest involves melanocortin receptor biology. Researchers continue to examine how activation of various melanocortin receptor subtypes influences hormonal regulation, neurotransmitter systems, and central nervous system signaling pathways. Additional investigations have evaluated PT-141 within broader studies of neuroendocrinology, reproductive biology, behavioral physiology, and autonomic nervous system regulation. These findings have contributed to growing scientific understanding of the melanocortin system and its role in coordinating complex physiological responses. As research into melanocortin receptor signaling continues to advance, PT-141 remains an important investigational peptide for studying neuroendocrine function, receptor pharmacology, and central nervous system communication. Further studies are necessary to fully characterize its biological mechanisms and broader applications within biomedical science.

Key areas of research:

• Neuroscience Research
• Neuroendocrinology Research
• Melanocortin Receptor Research
• Behavioral Science Research
• Hormonal Signaling Research
• Central Nervous System Research
• Neurotransmitter Research
• Reproductive Biology Research
• Cellular Signaling Research
• Endocrinology Research

References

• Bremelanotide (PT-141) and Melanocortin Receptor Pharmacology
• Alpha-MSH Analogs and Melanocortin Signaling Pathways

References are provided for research context only and do not constitute medical claims. PT-141 is sold for laboratory research use only.